Your browser doesn't support javascript.
loading
The multiple benefits of second-generation ß-lactamase inhibitors in treatment of multidrug-resistant bacteria.
de Sousa Coelho, F; Mainardi, J-L.
Affiliation
  • de Sousa Coelho F; Faculdade de Engenharia da Universidade do Porto, Instituto de Ciências Biomédicas Abel Salazar, Porto, Portugal. Electronic address: up201605835@fe.up.pt.
  • Mainardi JL; Centre de recherche des Cordeliers, INSERM UMRS 1138, Sorbonne université, université de Paris, Paris, France; Service de microbiologie, hôpital européen Georges-Pompidou, Assistance publique-Hôpitaux de Paris, centre-université de Paris, Paris, France. Electronic address: jean-luc.mainardi@crc.jussieu.fr.
Infect Dis Now ; 51(6): 510-517, 2021 Sep.
Article in En | MEDLINE | ID: mdl-33870896
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug Resistance, Multiple, Bacterial / Beta-Lactamase Inhibitors Language: En Journal: Infect Dis Now Year: 2021 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug Resistance, Multiple, Bacterial / Beta-Lactamase Inhibitors Language: En Journal: Infect Dis Now Year: 2021 Document type: Article